RPS Biologiques Inc.
$49,645.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- December 3, 2018 – March 31, 2021
- Reference
- nrc-cnrc:172-2018-2019-Q3-916911
Published purpose
Infections by the parasitic copepod sea lice continue to be a challenge to most Atlantic salmon farming regions of the world, including Atlantic Canada. These host-specific parasites are very pathogenic to salmonid species (e.g. Atlantic salmon) especially populations in cage culture where the stocking density is unnaturally high. Large numbers of sea lice can quickly cause severe skin and tissue damage resulting in fish stress and mortality. RPS Biologiques has developed a novel compound that will undergo pilot-testing prior to further pre-commercial development, to determine and compare the efficacy with other commercially available bath treatments.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.